Digoxin: The good and the bad.
Trends in cardiovascular medicine, 2016 O. Ziff, D. Kotecha
semanticscholar +1 more source
A Systematic Review and Classification of the Effects of P-glycoprotein Inhibitors and Inducers in Humans, Using Digoxin, Fexofenadine, and Dabigatran as Probe Drugs. [PDF]
Clin PharmacokinetCoumau C, Csajka C.
europepmc +1 more source
Letter: Serum digoxin in patients with thyroid disease. [PDF]
, 1975 Kevin Watters, G.H. Tomkin
openalex +1 more source
Concomitant Drug Interactions With Non-Vitamin K Oral Anticoagulants Are Associated With Bleeding and Mortality Risk in Patients With Nonvalvular Atrial Fibrillation. [PDF]
J Am Heart AssocWong CK +8 more
europepmc +1 more source
Comparison of medigoxin and digoxin in the control of atrial fibrillation. [PDF]
, 1979 Pamela Coburn, GM Kongola, G. E. Mawer
openalex +1 more source
Digoxin reduces atherosclerosis in apolipoprotein E‐deficient mice
British Journal of Pharmacology, 2016 Huairui Shi +11 more
semanticscholar +1 more source
RORγt Mediates Angiotensin II-Induced Pressor Responses, Microglia Activation, and Neuroinflammation by Disrupting the Blood-Brain Barrier in Rats. [PDF]
J Am Heart AssocYu Y +5 more
europepmc +1 more source
Use of Gelatin-Coated Charcoal in Digoxin Immunoassay [PDF]
, 1973 Axel Brock
openalex +1 more source
Digoxin in Heart Failure with a Reduced Ejection Fraction: A Risk Factor or a Risk Marker?
The Cardiology, 2016 D. Konstantinou +2 more
semanticscholar +1 more source